Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
46 studies found for:    "Membranous nephropathy"
Show Display Options
Rank Status Study
21 Completed Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
Conditions: Glomerulonephritis, Membranous;   Glomerulosclerosis, Focal
Interventions: Drug: prednisolone and mycophenolate mofetil;   Drug: prednisolone and chlorambucil
22 Completed Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
Conditions: Idiopathic Membranous Nephropathy;   Nephrotic Syndrome
Intervention: Drug: tacrolimus combined with prednisone
23 Completed Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Conditions: Membranous Glomerulonephritis;   Lupus Membranous Nepropathy
Intervention: Drug: Sirolimus
24 Completed The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
Conditions: Nephrotic Syndrome;   Glomerulonephritis;   Membranous Nephropathy
Intervention: Drug: lansoprazole, amoxicillin, clarithromycin
25 Active, not recruiting Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG)
Condition: Nephrotic Syndrome Secondary to Idiopathic Membranous Glomerulonephritis
Interventions: Drug: tacrolimus;   Drug: tacrolimus and mycophenolate mofetil
26 Terminated Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: TRU-015
27 Unknown  A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy
Conditions: Idiopathic Membranous Nephropathy;   Proteinuria;   Spontaneous Remission;   Steroid Nephropathy;   Cyclosporin Overdose
Intervention: Drug: steroid & Cyclosporin
28 Unknown  Phospholipase A2 Receptor (PLA2R1) Autoantibodies in Membranous Nephropathy in Kidney Transplantation
Condition: Kidney Transplantation
Intervention: Other: Anticorps anti-PLA2R1
29 Recruiting Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Conditions: Nephrotic Syndrome;   Proteinuria;   Autoimmune Disease;   Glomerular Disease;   Membranous Glomerulonephritis
Interventions: Drug: Rituximab Infusion;   Drug: Oral Cyclosporine
30 Unknown  A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
Condition: Glomerulonephritis
Intervention: Drug: Adrenocorticotrophic hormone ACTH
31 Active, not recruiting
Has Results
A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
Condition: Glomerulonephritis, Membranous
Intervention: Drug: belimumab
32 Completed Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
Conditions: Hepatocellular Carcinoma;   Hepatitis B
Interventions: Procedure: PEIT;   Procedure: TOCE;   Procedure: TOCE plus PEIT;   Procedure: TOCE plus RFA;   Dietary Supplement: MGN-3;   Drug: Entecavir
33 Recruiting Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
Conditions: Advanced Cancers;   Melanoma
Interventions: Drug: MGN1703;   Drug: Ipilimumab
34 Completed A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
Conditions: Lupus Nephritis;   Glomerulonephritis, Membranous
Interventions: Drug: prednisolone and mycophenolate mofetil;   Drug: prednisolone and tacrolimus
35 Recruiting Nephrotic Syndrome Study Network
Conditions: Minimal Change Disease (MCD);   Membranous Nephropathy;   Glomerulosclerosis, Focal Segmental
Intervention:
36 Active, not recruiting Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
Condition: Small Cell Lung Cancer
Interventions: Drug: MGN1703;   Other: Standard of care
37 Completed Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV
Condition: Hepatitis C, Chronic
Interventions: Drug: pegylated IFN;   Dietary Supplement: Biobran;   Drug: Ribavirin
38 Completed A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
Condition: Healthy
Interventions: Drug: MGN-Placebo;   Drug: Placebo-MGN
39 Completed Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
Condition: Advanced Colorectal Carcinoma
Interventions: Drug: MGN1703;   Drug: Placebo
40 Unknown  Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Conditions: Glomerulonephritis, Membranous;   Neonatal Diseases and Abnormalities;   Hemochromatosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.